Medical/Pharmaceuticals

ScImage Lauded by Frost & Sullivan for Its Cloud-based Enterprise Imaging Platform, PICOM365

Its seamless integration across imaging programs and tools give physicians single-platform access to all the tools needed to view and interpret images and videos from anywhere SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American cloud-based enterp...

2021-02-23 22:00 1905

Rheumatology Clinical Researcher Professor David Hunter Joins George Clinical Scientific Leadership

OVERLAND PARK, Kan., Feb. 23, 2021 /PRNewswire/ -- David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based inAustralia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter's researc...

2021-02-23 22:00 1773

INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa

Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflects INOVIO's focus on and continued commitment to the fight against infectious diseases Trial fully f...

2021-02-23 21:00 5760

RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.

TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plans to expand the Company's global Phase 2/3 study of opaganib[1] ...

2021-02-23 20:33 4866

For third year straight, Elekta named one of the world's most ethical companies by Ethisphere

STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has again been recognized as one of theWorld's Most Ethical Companies®  by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. The honor is bestowed upo...

2021-02-23 20:02 3757

Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China

CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders,Kathy He, R...

2021-02-23 20:00 4310

New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19

SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ -- Recently, Prof. Caisheng Wu and Prof.Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and produced by Y...

2021-02-23 17:05 3013

Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology

Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/N...

2021-02-23 16:00 1592

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

* Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) * The proceeds will support the continued development and expansion of Clover's pipeline of protein-based vaccines and biologic cancer therapies CHENGDU, China, Feb. 23, 2021 /PRNe...

2021-02-23 10:59 3391

The BCMA CAR-T Co-developed by Innovent and IASO Was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-02-23 09:22 6591

AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs

GUANGZHOU, China, Feb. 23, 2021 /PRNewswire/ -- AnchorDx Medical Co., Ltd. ("AnchorDx") announced the completion of aUSD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment...

2021-02-23 09:02 2870

Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A

LACHEN, Switzerland, Feb. 23, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journalThrombosis and Haemosta...

2021-02-23 00:51 4230

Frost & Sullivan Reveals Regional Trends and Cutting-edge Technologies in the Global MRI Market

Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advancements and Emerging Applications in the Global ...

2021-02-23 00:48 1508
1 ... 390391392393394

Week's Top Stories